These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7774236)
1. Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infections. Fink MP Crit Care Med; 1995 Jun; 23(6):989-91. PubMed ID: 7774236 [No Abstract] [Full Text] [Related]
2. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Bone RC; Balk RA; Fein AM; Perl TM; Wenzel RP; Reines HD; Quenzer RW; Iberti TJ; Macintyre N; Schein RM Crit Care Med; 1995 Jun; 23(6):994-1006. PubMed ID: 7774238 [TBL] [Abstract][Full Text] [Related]
4. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis]. van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630 [No Abstract] [Full Text] [Related]
6. Human monoclonal antibodies in sepsis. de Koning J; Westendorp RG Neth J Med; 1992 Apr; 40(3-4):215. PubMed ID: 1603215 [No Abstract] [Full Text] [Related]
7. Antibody to endotoxin in the treatment of gram-negative sepsis. Schentag JJ JAMA; 1992 May; 267(17):2326-7. PubMed ID: 1564766 [No Abstract] [Full Text] [Related]
8. Antibody to endotoxin in the treatment of gram-negative sepsis. Spalter J JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564764 [No Abstract] [Full Text] [Related]
9. Antibody to endotoxin in the treatment of gram-negative sepsis. McCabe WR JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763 [No Abstract] [Full Text] [Related]
10. Antibody to endotoxin in the treatment of gram-negative sepsis. van Deventer S JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765 [No Abstract] [Full Text] [Related]
11. A model for rational introduction of new and expensive medicines. Bell E; McCartney C Postgrad Med J; 1995 Feb; 71(832):86-9. PubMed ID: 7724440 [TBL] [Abstract][Full Text] [Related]
12. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis. Smith CR; Straube RC; Ziegler EJ Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120 [TBL] [Abstract][Full Text] [Related]
13. Role of immunomodulator therapy in sepsis. Caplan ES Am J Surg; 1993 Feb; 165(2A Suppl):20S-25S. PubMed ID: 8438996 [TBL] [Abstract][Full Text] [Related]
14. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Barriere SL; Guglielmo BJ Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812 [TBL] [Abstract][Full Text] [Related]
15. Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsis. Greenberg RN; Wilson KM; Kunz AY; Wedel NI; Gorelick KJ Crit Care Med; 1992 Jun; 20(6):730-5. PubMed ID: 1597023 [TBL] [Abstract][Full Text] [Related]